AAAAAA

   
Results: 1-9 |
Results: 9
Pharmacological properties of peptides derived from stromal cell-derived factor 1: Study on human polymorphonuclear cells
Authors: Heveker, N Tissot, M Thuret, A Schneider-Mergener, J Alizon, M Roch, M Marullo, S
Citation: N. Heveker et al., Pharmacological properties of peptides derived from stromal cell-derived factor 1: Study on human polymorphonuclear cells, MOLEC PHARM, 59(6), 2001, pp. 1418-1425
Antigenically distinct conformations of CXCR4
Authors: Baribaud, F Edwards, TG Sharron, M Brelot, T Heveker, N Price, K Mortari, F Alizon, M Tsang, M Doms, RW
Citation: F. Baribaud et al., Antigenically distinct conformations of CXCR4, J VIROLOGY, 75(19), 2001, pp. 8957-8967
Determination of coreceptor usage of human immunodeficiency virus type 1 from patient plasma samples by using a recombinant phenotypic assay
Authors: Trouplin, V Salvatori, F Cappello, F Obry, V Brelot, A Heveker, N Alizon, M Scarlatti, G Clavel, F Mammano, F
Citation: V. Trouplin et al., Determination of coreceptor usage of human immunodeficiency virus type 1 from patient plasma samples by using a recombinant phenotypic assay, J VIROLOGY, 75(1), 2001, pp. 251-259
SDF-1-induced activation of ERK enhances HIV-1 expression
Authors: Montes, M Tagieva, NE Heveker, N Nahmias, C Baleux, F Trautmann, A
Citation: M. Montes et al., SDF-1-induced activation of ERK enhances HIV-1 expression, EUR CYTOKIN, 11(3), 2000, pp. 470-477
Mutation of a conserved residue (D123) required for oligomerization of human immunodeficiency virus type 1 Nef protein abolishes interaction with human thioesterase and results in impairment of Nef biological functions
Authors: Liu, LX Heveker, N Fackler, OT Arold, S Le Gall, S Janvier, K Peterlin, BM Dumas, C Schwartz, O Benichou, S Benarous, R
Citation: Lx. Liu et al., Mutation of a conserved residue (D123) required for oligomerization of human immunodeficiency virus type 1 Nef protein abolishes interaction with human thioesterase and results in impairment of Nef biological functions, J VIROLOGY, 74(11), 2000, pp. 5310-5319
Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities
Authors: Brelot, A Heveker, N Montes, M Alizon, M
Citation: A. Brelot et al., Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities, J BIOL CHEM, 275(31), 2000, pp. 23736-23744
Shared usage of the chemokine receptor CXCR4 by primary and laboratory-adapted strains of feline immunodeficiency virus
Authors: Richardson, J Pancino, G Merat, R Leste-Lasserre, T Moraillon, A Schneider-Mergener, J Alizon, M Sonigo, P Heveker, N
Citation: J. Richardson et al., Shared usage of the chemokine receptor CXCR4 by primary and laboratory-adapted strains of feline immunodeficiency virus, J VIROLOGY, 73(5), 1999, pp. 3661-3671
Effect of mutations in the second extracellular loop of CXCR4 on its utilization by human and feline immunodeficiency viruses
Authors: Brelot, A Heveker, N Adema, K Hosie, MJ Willett, B Alizon, M
Citation: A. Brelot et al., Effect of mutations in the second extracellular loop of CXCR4 on its utilization by human and feline immunodeficiency viruses, J VIROLOGY, 73(4), 1999, pp. 2576-2586
Suppression of platelet aggregation by Bordetella pertussis adenylate cyclase toxin
Authors: Iwaki, M Kamachi, K Heveker, N Konda, T
Citation: M. Iwaki et al., Suppression of platelet aggregation by Bordetella pertussis adenylate cyclase toxin, INFEC IMMUN, 67(6), 1999, pp. 2763-2768
Risultati: 1-9 |